Clinical Trial Update: Effect of Vancomycin After Catheter Replacement [Phase 4]

View source ↗

Summary

Clinical trial update on vancomycin after catheter replacement for central line-associated bloodstream infections (CLABSI) in Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection
• Central Line-associated Bloodstream Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: University of Zurich | Conditions: Central Line-associated Bloodstream Infection (CLABSI), Catheter-related Bloodstream Infection | Phase 4 | Status: UNKNOWN